Home > News > NanoViricides to raise $40M through occasional stock sales
March 8th, 2010
NanoViricides to raise $40M through occasional stock sales
Abstract:
Drug maker NanoViricides Inc. has filed documents stating that it will look to raise up to $40 million through the occasional sale of company stock, for as-yet undefined general corporate purposes.
The shelf registration statement filed with the U.S. Securities and Exchange Commission has not yet become effective, officials said, so no immediate offering has begun. The registration covers a sale period of three years.
Source:
masshightech.com
Related Links |
Related News Press |
News and information
Researchers develop artificial building blocks of life March 8th, 2024
Investments/IPO's/Splits
Daikin Industries becomes OCSiAl shareholder July 27th, 2021
INBRAIN Neuroelectronics raises over €14M to develop smart graphene-based neural implants for personalised therapies in brain disorders March 26th, 2021
180 Degree Capital Corp. Issues Second Open Letter to the Board and Shareholders of Enzo Biochem, Inc. March 26th, 2021
Announcements
What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024
Nanoscale CL thermometry with lanthanide-doped heavy-metal oxide in TEM March 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||